JP2017525717A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525717A5
JP2017525717A5 JP2017510567A JP2017510567A JP2017525717A5 JP 2017525717 A5 JP2017525717 A5 JP 2017525717A5 JP 2017510567 A JP2017510567 A JP 2017510567A JP 2017510567 A JP2017510567 A JP 2017510567A JP 2017525717 A5 JP2017525717 A5 JP 2017525717A5
Authority
JP
Japan
Prior art keywords
phenyl
methanone
pyrrolidin
methyl
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017510567A
Other languages
English (en)
Japanese (ja)
Other versions
JP6434614B2 (ja
JP2017525717A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/001570 external-priority patent/WO2016026549A1/en
Publication of JP2017525717A publication Critical patent/JP2017525717A/ja
Publication of JP2017525717A5 publication Critical patent/JP2017525717A5/ja
Application granted granted Critical
Publication of JP6434614B2 publication Critical patent/JP6434614B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017510567A 2014-08-22 2015-07-30 インダゾール Expired - Fee Related JP6434614B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14002929 2014-08-22
EP14002929.9 2014-08-22
PCT/EP2015/001570 WO2016026549A1 (en) 2014-08-22 2015-07-30 Indazoles

Publications (3)

Publication Number Publication Date
JP2017525717A JP2017525717A (ja) 2017-09-07
JP2017525717A5 true JP2017525717A5 (enExample) 2018-08-02
JP6434614B2 JP6434614B2 (ja) 2018-12-05

Family

ID=51690171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017510567A Expired - Fee Related JP6434614B2 (ja) 2014-08-22 2015-07-30 インダゾール

Country Status (9)

Country Link
US (1) US9862717B2 (enExample)
EP (1) EP3183239B1 (enExample)
JP (1) JP6434614B2 (enExample)
CN (1) CN106573932B (enExample)
AU (1) AU2015306458B2 (enExample)
CA (1) CA2958508A1 (enExample)
ES (1) ES2703851T3 (enExample)
IL (1) IL250306B (enExample)
WO (1) WO2016026549A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101731624B1 (ko) 2014-07-01 2017-05-04 광주과학기술원 세포 리프로그래밍 유도용 조성물
KR102700664B1 (ko) * 2017-08-07 2024-08-29 조인트 스탁 컴퍼니 “바이오케드” Cdk8/19 저해제로서 새로운 헤테로사이클릭 화합물
WO2019068613A1 (en) 2017-10-02 2019-04-11 Boehringer Ingelheim International Gmbh NOVEL [1,6] NAPHTHYRIDINE COMPOUNDS AND DERIVATIVES AS CDK8 / CDK19 INHIBITORS
UY38765A (es) * 2019-06-27 2021-01-29 Biogen Ma Inc Derivados de 2h-indazol y su uso en el tratamiento de enfermedades
EP4255904A2 (en) * 2020-12-03 2023-10-11 Domain Therapeutics Novel par-2 inhibitors
IL303451A (en) 2020-12-16 2023-08-01 Amgen Inc Prmts inhibitors
WO2024148247A2 (en) * 2023-01-06 2024-07-11 Ajax Therapeutics, Inc. Azaindazoles as jak2 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9811178B (en) * 1997-12-13 2000-06-07 Bristol Myers Squibb Co Use of pyrazolo (3,4-b) pyridine as cyclin dependent kinase inhibitors.
ES2236217T3 (es) * 2000-04-25 2005-07-16 Bristol-Myers Squibb Company Uso de 5.tio.,sulfinil- y sulfonilpirazolo 3,4-b)-piridinas como inhibidores de la quinasa dependiente de la ciclina.
CN101437519A (zh) * 2006-03-31 2009-05-20 艾博特公司 吲唑化合物
WO2011000566A2 (en) * 2009-06-30 2011-01-06 Savira Pharmaceuticals Gmbh Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
JP2013501792A (ja) * 2009-08-10 2013-01-17 サミュメッド リミテッド ライアビリティ カンパニー Wnt/b−カテニンシグナル伝達経路阻害剤としてのインダゾールおよびその治療的使用
CA2885392A1 (en) * 2012-12-10 2014-06-19 Zhanling CHENG Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2017525717A5 (enExample)
JP2012525431A5 (enExample)
JP2010532768A5 (enExample)
JP2015537020A5 (enExample)
JP2014528433A5 (enExample)
JP2014508811A5 (enExample)
JP2009536620A5 (enExample)
JP2013510120A5 (enExample)
JP2008535902A5 (enExample)
JP2015511609A5 (enExample)
JP2011517453A5 (enExample)
JP2015522650A5 (enExample)
JP2008535903A5 (enExample)
JP2010509356A5 (enExample)
MY145465A (en) Diaminopyrimidines as p2x3 and p2x2/3 antagonists.
RU2013130253A (ru) 7-деазапуриновые регуляторы метилтрансферазы гистонов и способы их применения
JP2016516043A5 (enExample)
ME02838B (me) 3,4-dihidroizokinolin-2(1h)-ilni spojevi
RU2009120229A (ru) Производные хинуклидинола в качестве антагонистов мускариновых рецепторов
JP2017530185A5 (enExample)
MY139941A (en) Indole derivatives
JP2015502371A5 (enExample)
JP2016513681A5 (enExample)
JP2012518634A5 (enExample)
JP2020505354A5 (enExample)